TABLE 4

Clinical characteristics of patients with Acinetobacter calcoaceticus-Acinetobacter baumannii complex bacteremia, stratified by 14-day mortality rate

VariableTigecycline group (n = 17)Comparison group (n = 65)
Survivors (n = 10)Nonsurvivors (n = 7)P valueSurvivors (n = 56)Nonsurvivors (n = 9)P value
Male (no. [%])7 (70.0)5 (71.4)>0.99942 (75.0)8 (88.9)0.446
Age (median [IQR]) (yr)78 (62.75–83)80 (61–84)>0.99977.5 (70–82)65 (57–78.5)0.089
APACHE II score within 24 h of the onset of bacteremia (median [IQR])25.5 (18.25–28.25)31 (29–33)0.03124 (21–29.75)30 (25.5–35)0.047
Duration of tigecycline therapy (median [IQR]) (days)13 (8–21.25)9 (4–15)0.171
Mechanical ventilator use at bacteremia onset (no. [%])7 (70.0)6 (85.7)0.60327 (48.2)5 (55.6)0.733
Acquired in intensive care unit (no. [%])7 (70.0)6 (85.7)0.60347(83.9)6 (66.7)0.349
Isolates with A. baumannii (no. [%])4 (40.0)7 (100.0)0.03556 (100)9 (100)
Dual appropriate antimicrobial agent (no. [%])2 (20.0)2 (28.6)>0.9994 (7.1)0 (0)>0.999